General Atlantic, Nautic Partners and The Vistria Group completed the acquisition of PANTHERx Rare from Centene for $1.45bn.

General Atlantic, a global growth equity firm, Nautic Partners, a middle-market private equity firm, and The Vistria Group, a private equity firm, completed the acquisition of PANTHERx Rare, a specialty pharmacy company, from Centene, a health care programs provider, for $1.45bn. "PANTHERx transforms lives by providing access solutions to people living with rare medical conditions. Our investment was a collaborative effort to bring focus to an area that not only has been significantly underserved but also offers a wealth of opportunity to enhance the lives of patients," Jon Maschmeyer, The Vistria Group Senior Partner and Co-Head of Healthcare.